Author

G. Brandacher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1

Frequent Co-Authors

G. Raimondi· 2 shared M. Iglesias· 2 shared A. Arun· 1 shared B. C. Oh· 1 shared B. H. Johnstone· 1 shared B. Lam· 1 shared C. Talbot· 1 shared D. Gu· 1 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. Raimondi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A short course of Tofacitinib sustains the immunoregulatory effect of CTLA4-Ig in presence of inflammatory cytokines and promotes long-term survival of murine cardiac allografts

M. Iglesias, S. Khalifian, B. C. Oh, Y. Zhang, D. Miller, S. Beck, G. Brandacher, G. Raimondi

This study shows that combining Tofacitinib with CTLA4-Ig improves cardiac allograft survival by reducing effector T cells and increasing regulatory T cells in mice.

bioRxiv · Nov 18, 2020Immunology

IDENTIFICATION AND CHARACTERIZATION OF A LARGE SOURCE OF PRIMARY MESENCHYMAL STEM CELLS TIGHTLY ADHERED TO BONE SURFACES OF HUMAN VERTEBRAL BODY MARROW CAVITIES

B. H. Johnstone, H. M. Miller, M. R. Beck, D. Gu, S. Thirumala, M. LaFontaine, G. Brandacher, e. J. Woods

The paper identifies and characterizes a large source of primary mesenchymal stem cells (MSC) tightly adhered to bone surfaces in human vertebral body marrow cavities, demonstrating their potential to reduce manufacturing costs and variability in MSC therapy.

bioRxiv · May 4, 2020Bioengineering

Type-I interferons inhibit interleukin-10 signaling and favor type 1 diabetes development in NOD mice

M. Iglesias, A. Arun, M. Chicco, B. Lam, C. Talbot, V. Ivanova, W. P. A. Lee, G. Brandacher, G. Raimondi

This study shows that type-I interferons inhibit IL-10 signaling in T cells, promoting type 1 diabetes in NOD mice by altering T cell responses and spatial localization.

bioRxiv · Feb 1, 2018Immunology